5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC en la toma de decisiones clínicas en su ejercicio diario, así como en la …

Objective To describe the efficacy, superiority and safety profile of the first-in-class
angiotensin receptor-neprilysin inhibitor “Sacubitril/Valsartan” as compared to angiotensin …

The prevalence of Heart Failure (HF) has increased over time. Ischemic heart failure
accounts for 50% of HF, which results from ischemic coronary heart diseases such as …

Abstract Stowarzyszenia ESC: Acute Cardiovascular Care Association (ACCA), European
Association for Cardiovascular Prevention and Rehabilitation (EACPR), European …

Objectives: The objective of this study was to determine the cost-effectiveness and cost per
quality-adjusted life year (QALY) gained of sacubitril-valsartan relative to enalapril for …

Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with
heart failure (HF). The main mechanism for increasing serum NP levels, which is …

Background Sacubitril/valsartan has been shown to improve mortality and reduce
hospitalizations in patients with heart failure (HF) with reduced ejection fraction (HFrEF) …

Background: Sacubitril–valsartan therapy reduces cardiovascular mortality compared with
enalapril therapy in patients with heart failure with reduced ejection fraction. Objective: To …

RH4W it has been shown that the outcome of disease may be favourably influenced by the
thorough application of clinical recommendations. Surveys and registries are needed to …